Xtant Medical Holdings, Inc.Xtant Medical Holdings, Inc.Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪71.44 M‬EUR
−0.03EUR
‪−15.89 M‬EUR
‪113.28 M‬EUR
‪110.73 M‬
Beta (1Y)
1.10
Employees (FY)
232
Change (1Y)
+17 +7.91%
Revenue / Employee (1Y)
‪488.26 K‬EUR
Net income / Employee (1Y)
‪−68.49 K‬EUR

About Xtant Medical Holdings, Inc.


CEO
Sean E. Browne
Headquarters
Belgrade
Founded
2006
ISIN
US98420P3082
FIGI
BBG01JYXK6C8
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. The company was founded in 2006 and is headquartered in Belgrade, MT.

Check out other big names from the same industry as XMS.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of XMS is 0.54 EUR — it hasn't changed in the past 24 hours. Watch Xtant Medical Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Xtant Medical Holdings, Inc. stocks are traded under the ticker XMS.
XMS stock has risen by 1.89% compared to the previous week, the month change is a 1.89% rise, over the last year Xtant Medical Holdings, Inc. has showed a −3.57% decrease.
We've gathered analysts' opinions on Xtant Medical Holdings, Inc. future price: according to them, XMS price has a max estimate of 1.77 EUR and a min estimate of 1.32 EUR. Watch XMS chart and read a more detailed Xtant Medical Holdings, Inc. stock forecast: see what analysts think of Xtant Medical Holdings, Inc. and suggest that you do with its stocks.
XMS reached its all-time high on Dec 5, 2023 with the price of 1.36 EUR, and its all-time low was 0.32 EUR and was reached on Apr 11, 2025. View more price dynamics on XMS chart.
See other stocks reaching their highest and lowest prices.
XMS stock is 0.93% volatile and has beta coefficient of 1.10. Track Xtant Medical Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Xtant Medical Holdings, Inc. there?
Today Xtant Medical Holdings, Inc. has the market capitalization of ‪71.44 M‬, it has increased by 3.93% over the last week.
Yes, you can track Xtant Medical Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Xtant Medical Holdings, Inc. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
XMS earnings for the last quarter are −0.08 EUR per share, whereas the estimation was −0.01 EUR resulting in a −700.18% surprise. The estimated earnings for the next quarter are 0.00 EUR per share. See more details about Xtant Medical Holdings, Inc. earnings.
Xtant Medical Holdings, Inc. revenue for the last quarter amounts to ‪30.06 M‬ EUR, despite the estimated figure of ‪26.62 M‬ EUR. In the next quarter, revenue is expected to reach ‪27.94 M‬ EUR.
XMS net income for the last quarter is ‪3.01 M‬ EUR, while the quarter before that showed ‪53.61 K‬ EUR of net income which accounts for ‪5.52 K‬% change. Track more Xtant Medical Holdings, Inc. financial stats to get the full picture.
No, XMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 29, 2025, the company has 232 employees. See our rating of the largest employees — is Xtant Medical Holdings, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Xtant Medical Holdings, Inc. EBITDA is ‪3.81 M‬ EUR, and current EBITDA margin is −6.69%. See more stats in Xtant Medical Holdings, Inc. financial statements.
Like other stocks, XMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Xtant Medical Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Xtant Medical Holdings, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Xtant Medical Holdings, Inc. stock shows the neutral signal. See more of Xtant Medical Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.